Search

Search Constraints

You searched for: Author/Creator Neven, P.

Search Results

34. P017 Abemaciclib + endocrine therapy (ET) for HR+, HER2-, node-positive, high-risk EBC: results from a pre-planned monarchE overall survival (OS) interim analysis (IA), including 4-year efficacy outcomes. (April 2023)

37. Plasma markers showing differential baseline expression in relapsing versus non-relapsing patients with hormone sensitive breast tumors. (October 2020)